Adrenomedullin Therapy in Moderate to Severe COVID-19

The 2019 coronavirus (COVID-19) pandemic is still in progress, and a significant number of patients have presented with severe illness. Recently introduced vaccines, antiviral medicines, and antibody formulations can suppress COVID-19 symptoms and decrease the number of patients exhibiting severe di...

Descripción completa

Detalles Bibliográficos
Autores principales: Kita, Toshihiro, Kitamura, Kazuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945653/
https://www.ncbi.nlm.nih.gov/pubmed/35327335
http://dx.doi.org/10.3390/biomedicines10030533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945653/
https://www.ncbi.nlm.nih.gov/pubmed/35327335
http://dx.doi.org/10.3390/biomedicines10030533

Ejemplares similares